Category: Protocol 5

They say no news is good news, and in this case, it’s true—though I wouldn’t generally trust that old phrase. For doses 4 and 5, I did exactly the same as for doses 2 and 3, experiencing no side effects. But then came dose 6, my last of Protocol 5. I foolishly decided to eat a piece of toast in …

For the second dose of this protocol (Friday, June 28th), I stuck with the enteric-coated capsules. This is becoming my new standard unless I switch to subcutaneous injections, which seems unlikely, at least not before my following scan. If my breast tumour disappeared back in the fall of 2023 when I was taking DON orally (and losing half to stomach …

Hello everyone, As I mentioned in my previous post, I decided to try a new method to improve DON absorption. Ideally, an IV or subcutaneous administration would be best, but that’s a bit above my pay grade right now. I might consider subcutaneous in the future if I can figure out the reconstitution values from previous studies. I haven’t delved …

Hello everyone, I recently revisited the effectiveness of my current method for taking 6-Diazo-5-oxo-L-norleucine (DON) and discovered some potentially significant improvements. After discussing it with a researcher from Seyfried’s lab, I learned that DON, like many small molecules and amino acid derivatives, is primarily absorbed in the small intestine. This insight led me to reconsider how I administer DON to …